DIPG-66. FEASIBILITY AND APPLICABILITY OF MOLECULAR GUIDED THERAPY IN HIGH GRADE GLIOMA/DIFFUSE MIDLINE GLIOMA: RESULTS FROM BEAT CHILDHOOD CANCER NMTRC-009 MOLECULAR GUIDED THERAP...

por Harrod, Virginia, Nagulapally, Abhinav, Lewis, Elizabeth, Sholler, Giselle
Publicado 2020

Embryonic sympathoblasts transiently express TrkB in vivo and proliferate in response to brain-derived neurotrophic factor in vitro

por Straub, Jennifer A, Sholler, Giselle L Saulnier, Nishi, Rae
Publicado 2007

Identification of Let-7 miRNA Activity as a Prognostic Biomarker of SHH Medulloblastoma

por Westphal, Maximillian S., Lee, Eunjee, Schadt, Eric E., Sholler, Giselle S., Zhu, Jun
Publicado 2021

Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells

por Brard, Laurent, Singh, Rakesh K, Kim, Kyu Kwang, Lange, Thilo S, Sholler, Giselle L Saulier
Publicado 2009

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma

por Maser, Tyler, Rich, Maria, Hayes, David, Zhao, Ping, Nagulapally, Abhinav B., Bond, Jeffrey, Saulnier Sholler, Giselle
Publicado 2017

The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma

por Maser, Tyler, Zagorski, Joseph, Kelly, Shannon, Ostrander, Anna, Goodyke, Austin, Nagulapally, Abhinav, Bond, Jeffrey, Park, Yeonhee, Saulnier Sholler, Giselle
Publicado 2020

BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma

por Zhao, Ping, Hall, Jacob, Durston, Mary, Voydanoff, Austin, VanSickle, Elizabeth, Kelly, Shannon, Nagulapally, Abhinav B, Bond, Jeffery, Saulnier Sholler, Giselle
Publicado 2017

ETMR-18. TARGETING Lin28 IN ETMR WITH ODC1 INHIBITOR DFMO

por Goodyke, Austin, Kelly, Shannon, Zagorski, Joseph, VanSickle, Elizabeth, Maser, Tyler, Sortwell, Caryl, Kemp, Christopher, Nagulapally, Abhinav, Dykema, Karl, Saulnier-Sholler, Giselle
Publicado 2020

Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma

por Lozier, Ann M., Rich, Maria E., Grawe, Anissa Pedersen, Peck, Anderson S., Zhao, Ping, Chang, Anthony Ting-Tung, Bond, Jeffrey P., Sholler, Giselle Saulnier
Publicado 2014

Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

por Cornelius, Albert, Foley, Jessica, Bond, Jeffrey, Nagulapally, Abhinav B., Steinbrecher, Julie, Hendricks, William P. D., Rich, Maria, Yendrembam, Sangeeta, Bergendahl, Genevieve, Trent, Jeffrey M., Sholler, Giselle S.
Publicado 2017

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

por Lewis, Elizabeth C., Kraveka, Jacqueline M., Ferguson, William, Eslin, Don, Brown, Valerie I., Bergendahl, Genevieve, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Zage, Peter, Rawwas, Jawhar, Rich, Maria, Lorenzi, Elizabeth, Broglio, Kristine, Berry, Donald, Saulnier Sholler, Giselle L.
Publicado 2020

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma

por Saulnier Sholler, Giselle L, Bond, Jeffrey P, Bergendahl, Genevieve, Dutta, Akshita, Dragon, Julie, Neville, Kathleen, Ferguson, William, Roberts, William, Eslin, Don, Kraveka, Jacqueline, Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal, Merchant, Melinda, Ashikaga, Takamaru, Hanna, Gina, Lescault, Pamela Jean, Siniard, Ashley, Corneveaux, Jason, Huentelman, Matthew, Trent, Jeffrey
Publicado 2015

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

por Sholler, Giselle L. Saulnier, Ferguson, William, Bergendahl, Genevieve, Bond, Jeffrey P., Neville, Kathleen, Eslin, Don, Brown, Valerie, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Parikh, Nehal S., Eshun, Francis, Zage, Peter, Rawwas, Jawhar, Sencer, Susan, Pankiewicz, Debra, Quinn, Monique, Rich, Maria, Junewick, Joseph, Kraveka, Jacqueline M.
Publicado 2018

Next generation metronomic chemotherapy—report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6–8 May 2016, Mumbai

por Pantziarka, Pan, Hutchinson, Lisa, André, Nicolas, Benzekry, Sébastien, Bertolini, Francesco, Bhattacharjee, Atanu, Chiplunkar, Shubhada, Duda, Dan G., Gota, Vikram, Gupta, Sudeep, Joshi, Amit, Kannan, Sadhana, Kerbel, Robert, Kieran, Mark, Palazzo, Antonella, Parikh, Aparna, Pasquier, Eddy, Patil, Vijay, Prabhash, Kumar, Shaked, Yuval, Sholler, Giselle Saulnier, Sterba, Jaroslav, Waxman, David J., Banavali, Shripad
Publicado 2016

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma

por Saulnier Sholler, Giselle L., Gerner, Eugene W., Bergendahl, Genevieve, MacArthur, Robert B., VanderWerff, Alyssa, Ashikaga, Takamaru, Bond, Jeffrey P., Ferguson, William, Roberts, William, Wada, Randal K., Eslin, Don, Kraveka, Jacqueline M., Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal S., Neville, Kathleen, Sender, Leonard, Higgins, Timothy, Kawakita, Masao, Hiramatsu, Kyoko, Moriya, Shun-suke, Bachmann, André S.
Publicado 2015

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma

por Kraveka, Jacqueline M., Lewis, Elizabeth C., Bergendahl, Genevieve, Ferguson, William, Oesterheld, Javier, Kim, Elizabeth, Nagulapally, Abhinav B., Dykema, Karl J., Brown, Valerie I., Roberts, William D., Mitchell, Deanna, Eslin, Don, Hanson, Derek, Isakoff, Michael S., Wada, Randal K., Harrod, Virginia L., Rawwas, Jawhar, Hanna, Gina, Hendricks, William P. D., Byron, Sara A., Snuderl, Matija, Serrano, Jonathan, Trent, Jeffrey M., Saulnier Sholler, Giselle L.
Publicado 2022